154 related articles for article (PubMed ID: 29395256)
1. Membrane attack complex (mac) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment.
Wang S; Wu M; Chiriboga L; Zeck B; Belmont HM
Semin Arthritis Rheum; 2018 Oct; 48(2):256-262. PubMed ID: 29395256
[TBL] [Abstract][Full Text] [Related]
2. Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study.
Wang S; Wu M; Chiriboga L; Zeck B; Goilav B; Wang S; Jimenez AL; Putterman C; Schwartz D; Pullman J; Broder A; Belmont HM
Lupus Sci Med; 2022 Jan; 9(1):. PubMed ID: 34996855
[TBL] [Abstract][Full Text] [Related]
3. Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.
Wilson HR; Medjeral-Thomas NR; Gilmore AC; Trivedi P; Seyb K; Farzaneh-Far R; Gunnarsson I; Zickert A; Cairns TD; Lightstone L; Cook HT; Pickering MC
Kidney Int; 2019 Mar; 95(3):655-665. PubMed ID: 30655025
[TBL] [Abstract][Full Text] [Related]
4. Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients.
Wang S; Broder A; Shao D; Kesarwani V; Boderman B; Aguilan J; Sidoli S; Suzuki M; Greally JM; Saenger YM; Rovin BH; Michelle Kahlenberg J
Semin Arthritis Rheum; 2023 Dec; 63():152263. PubMed ID: 37802003
[TBL] [Abstract][Full Text] [Related]
5. Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.
Park DJ; Kang JH; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee SS
Lupus; 2017 Oct; 26(11):1139-1148. PubMed ID: 28420060
[TBL] [Abstract][Full Text] [Related]
6. Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study.
Wang H; Xu J; Zhang X; Ren YL; Cheng M; Guo ZL; Zhang JC; Cheng H; Xing GL; Wang SX; Yu F; Zhao MH
Lupus; 2018 Apr; 27(4):545-555. PubMed ID: 28954590
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
9. The clinical relevance of repeat renal biopsies in the management of lupus nephritis: a South African experience.
Tannor EK; Bates WD; Moosa MR
Lupus; 2018 Apr; 27(4):525-535. PubMed ID: 28820361
[TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy.
Lai KN; Lo ST; Lai FM
Am J Pathol; 1989 Sep; 135(3):469-76. PubMed ID: 2675624
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
13. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.
Fiehn C; Hajjar Y; Mueller K; Waldherr R; Ho AD; Andrassy K
Ann Rheum Dis; 2003 May; 62(5):435-9. PubMed ID: 12695156
[TBL] [Abstract][Full Text] [Related]
14. Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.
Stoenoiu MS; Aydin S; Tektonidou M; Ravelingien I; le Guern V; Fiehn C; Remy P; Delahousse M; Petera P; Quémeneur T; Vasconcelos C; D'Cruz D; Gilboe IM; Jadoul M; Karras A; Depresseux G; Guillevin L; Cervera R; Cosyns JP; Houssiau FA;
Nephrol Dial Transplant; 2012 May; 27(5):1924-30. PubMed ID: 22110048
[TBL] [Abstract][Full Text] [Related]
15. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
Hanaoka H; Yamada H; Kiyokawa T; Iida H; Suzuki T; Yamasaki Y; Ooka S; Nagafuchi H; Okazaki T; Ichikawa D; Shirai S; Shibagaki Y; Koike J; Ozaki S
Arthritis Res Ther; 2017 Jan; 19(1):4. PubMed ID: 28086993
[TBL] [Abstract][Full Text] [Related]
16. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
17. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
18. [The repeated biopsy in patients with lupus nephritis].
Subils G; Alba P; Gobbi C; Astesana P; Babini A; Albiero E
Rev Fac Cien Med Univ Nac Cordoba; 2014; 71(4):165-70. PubMed ID: 25927882
[TBL] [Abstract][Full Text] [Related]
19. Renal outcomes among Egyptian lupus nephritis patients: a retrospective analysis of 135 cases from a single centre.
Mahmoud GA; Zayed HS; Ghoniem SA
Lupus; 2015 Mar; 24(3):331-8. PubMed ID: 25609684
[TBL] [Abstract][Full Text] [Related]
20. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
